Search
USFDA Guidance: Medical Devices with Indications Associated with Weight Loss - Premarket Considerations
Medical devices intended for weight management play an important role in addressing obesity and related health conditions. The U.S. Food and Drug Administration (FDA) has issued guidance to help manufacturers understand regulatory expectations when developing and submitting premarket applications for medical devices with indications associated with weight loss. The FDA guidance titled “ Medical Devices with Indications Associated with Weight Loss: Premarket Considerations ”
Sharan Murugan
Mar 152 min read
UK MHRA Guidance: GLP-1 Medicines for Weight Loss and Diabetes: What You Need to Know
In recent years, GLP-1 receptor agonists have gained widespread attention for their dual role in type 2 diabetes management and weight...
Sharan Murugan
Jun 13, 20252 min read
USFDA M.D Guidance: Med Dev Associated with Weight Loss & Voluntary Improvement Program
Recently (14th September, 2023) the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health released multiple...
Sharan Murugan
Sep 19, 20232 min read